Microbial Interactions with Protein Intake and Preterm Infant Body Composition: Secondary Analysis of a Randomized Trial.

Authors

Katie M Strobel, Heather B Jaspan, Sean M Gibbons, Ariel A Salas

Published in

The Journal of nutrition. Pages 101723. Jul 12, 2026. Epub Jul 12, 2026.

Abstract

Enteral protein supplementation improves preterm infant growth, and may impact body composition and the gut microbiota.
To identify effects of additional enteral protein supplementation on the gut microbiota and microbial and clinical drivers of body composition.
Secondary analysis of a masked randomized trial of additional enteral protein versus standard fortification in preterm infants born 25-28 weeks gestation (NCT03586102). Stool at weeks 4 and 8 underwent 16S rRNA sequencing; functional potential was predicted by PICRUSt2. Body composition was measured by air-displacement plethysmography at 36 weeks postmenstrual age (PMA). LASSO regression with multivariable linear regression identified body composition predictors.
Among 46 infants, gestational age (p=0.16) and sex (p=0.55) did not differ between groups. The protein group had higher week 4 Shannon diversity than standard fortification (median 1.2 vs. 0.87, p=0.049). Week 4 Shannon diversity was positively correlated with fat-free mass z-score at 36 weeks PMA (r²=0.34, p=0.02). Adjusting for covariates, the protein group had higher Peptoniphilus (β=1.6, padj=0.10) and lower Vibrio CLR abundance (β=-0.98, padj=0.10); 62 predicted metabolic pathways were lower in the protein group (FDR<0.20). In combined LASSO models, Bacillus abundance at week 4 was the strongest predictor of fat-free mass z-score (β=-0.17, p<0.001; R²=0.80) and fat mass z-score (β=-0.31, p<0.001; R²=0.66).
Additional protein supplementation was associated with fat-free mass z-score and alterations to the gut microbiota. Clinical variables and microbial variables were key predictors of body composition, suggesting that nutrition, clinical factors, and the gut microbiota jointly contribute to body composition in extremely preterm infants.
NCT03586102, https://clinicaltrials.gov/study/NCT04325308, registered in March 2020.

PMID:
42437569
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.